Natalizumab and Tyruko in Multiple Sclerosis Therapy Natalizumab is a monoclonal antibody that targets the alpha-4 integrin subunit, inhibiting the […]
Study Overview The study focused on the use of subcutaneous immunoglobulin (SCIg) therapy for patients diagnosed with chronic inflammatory demyelinating
Disease Background Chronic Idiopathic Demyelinating Polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function due
Therapeutic Mechanisms of GLP-1 in Pain Management GLP-1, or glucagon-like peptide-1, is a hormone that plays a multifaceted role in
Study Overview This study investigates the relationship between alpha power and brain functional connectivity in patients experiencing functional or dissociative
Abnormal Visual Processing Mechanisms Visual processing is a complex neurological function that involves the interpretation of visual information received from
Editorial: Abnormal visual processing Read Post »
Fascicular Architecture in Demyelinating Conditions Fascicular architecture refers to the structured organization of nerve fibers within a nerve bundle. In
Study Overview The research primarily investigates the effects of AMY-101, a peptide that inhibits complement C3, on brain injuries associated
Incidence of Intracranial Hemorrhage The occurrence of intracranial hemorrhage (ICH) among patients who have mechanical heart valves and are on
Study overview The research conducted on multiple sclerosis (MS) in 2026 aims to enhance our understanding of the disease’s progression
Multiple sclerosis: 2026 update Read Post »
